
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
in Human Pancreatic Cancer MiaPaCa-2 and Human Prostatic Cancer DU-145 Cells
Authors' Affiliation: Department of Surgery and Pharmacology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
Requests for reprints: Yong J. Lee, Department of Surgery, University of Pittsburgh, Hillman Cancer Center, 5117 Center Avenue, Room G.5a, Pittsburgh, PA 15213. Phone: 412-623-3268; Fax: 412-623-1010; E-mail: leeyj{at}msx.upmc.edu.
Purpose and Experimental Design: Tumor microenvironment is characterized by regions of fluctuating and chronic hypoxia, low extracellular pH, and nutrient depletion. Although it is well known that hypoxia stimulates the accumulation of hypoxia-inducible factor-1
(HIF-1
), the role of low extracellular pH and nutrient depletion on hypoxia up-regulation of HIF-1
is not well known. In this study, human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells were exposed to hypoxia in the presence or absence of glucose, glutamine, and/or pyruvate.
Results: We observed that low glucose and low glutamine, but not low pyruvate, effectively suppressed the elevation of HIF-1
level during hypoxia (0.1-1% oxygen). Deprivation of glutamine or glucose inhibited the accumulation of HIF-1
in the presence of MG-132, a protease inhibitor, regardless of oxygen tensions. Data from reverse transcription-PCR analysis revealed that the levels of HIF-1
mRNA were not significantly changed at different concentrations of glutamine or glucose under hypoxia. The amount of HIF-1
suppression was proportional to protein synthesis inhibition.
Conclusions: Our data suggest that glutamine or glucose deprivation inhibits the accumulation of HIF-1
under hypoxic conditions by disrupting translational processes rather than transcriptional or proteasomal degradation processes.
This article has been cited by other articles:
![]() |
M. Prentki and S. R. M. Madiraju Glycerolipid Metabolism and Signaling in Health and Disease Endocr. Rev., October 1, 2008; 29(6): 647 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dehne, U. Kerkweg, T. Otto, and J. Fandrey The HIF-1 response to simulated ischemia in mouse skeletal muscle cells neither enhances glycolysis nor prevents myotube cell death Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1693 - R1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, S. S. Li, R. Segersvard, L. Strommer, K.-G. Sundqvist, J. Holgersson, and J. Permert Hypoxia Inducible Factor-1 Mediates Effects of Insulin on Pancreatic Cancer Cells and Disturbs Host Energy Homeostasis Am. J. Pathol., February 1, 2007; 170(2): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Khakoo, S. Pati, S. A. Anderson, W. Reid, M. F. Elshal, I. I. Rovira, A. T. Nguyen, D. Malide, C. A. Combs, G. Hall, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma J. Exp. Med., May 15, 2006; 203(5): 1235 - 1247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |